Decision 20-D-11 of

regarding practices implemented in the treatment of Age-related macular degeneration (AMD) sector

Presentation of the decision


Information about the decision

Origin of the case Autorité de la concurrence (autosaisine)
  • Established practice(s)
  • Sanctions pécuniaires
Company(ies) involved
  • Novartis Pharma SAS, Novartis AG, Novartis Groupe France SA
  • Roche, Roche Holding AG
  • Genentech Inc.